Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%

CVE-2020-4949

EPSS 0.17% · P38
Get alerts for future matching vulnerabilitiesLog in to subscribe

I. Basic Information for CVE-2020-4949

Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
IBM WebSphere Application Server 7.0, 8.0, 8.5, and 9.0 is vulnerable to an XML External Entity Injection (XXE) attack when processing XML data. A remote attacker could exploit this vulnerability to expose sensitive information or consume memory resources. IBM X-Force ID: 192025.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
Ibm Websphere AS 代码问题漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Ibm Websphere AS(WebSphere AS)是美国国际商用机器公司(Ibm)公司的一个监控Servlet响应状态的服务。该服务负责监视部署资源模型的每个目的地应用程序服务器上的单个 servlet。 Ibm Websphere AS 7.0, 8.0, 8.5, and 9.0存在代码问题漏洞,攻击者可利用该漏洞可以向WebSphere AS传输恶意XML数据,以便读取文件、扫描站点或触发拒绝服务。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)

Affected Products

VendorProductAffected VersionsCPESubscribe
IBMWebSphere Application Server 7.0 -

II. Public POCs for CVE-2020-4949

#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC

III. Intelligence Information for CVE-2020-4949

登录查看更多情报信息。

IV. Related Vulnerabilities

V. Comments for CVE-2020-4949

No comments yet


Leave a comment